|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/12/23 LadRx Corp. 8-K/A:5 9/06/23 10:199K M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 8-K/A Amendment to Current Report HTML 36K
5: R1 Cover HTML 47K
8: XML IDEA XML File -- Filing Summary XML 11K
6: XML XBRL Instance -- form8-ka_htm XML 15K
7: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
3: EX-101.LAB Inline XBRL Taxonomy Extension Label Linkbase XML 96K
Document -- ladx-20230906_lab
4: EX-101.PRE Inline XBRL Taxonomy Extension Presentation XML 64K
Linkbase Document -- ladx-20230906_pre
2: EX-101.SCH Inline XBRL Taxonomy Extension Schema Document -- XSD 12K
ladx-20230906
9: JSON XBRL Instance as JSON Data -- MetaLinks 25± 34K
10: ZIP XBRL Zipped Folder -- 0001493152-23-036975-xbrl Zip 15K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i September 6, 2023
(Exact name of registrant as specified in its charter)
| i Delaware | i 000-15327 | i 58-1642740 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
i 11726 San Vicente Boulevard, i Suite 650
i Los Angeles, i California i 90049
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: i (310) i 826-5648
Former name or former address, if changed since last report: None
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(g) of the Act:
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
EXPLANATORY NOTE
i This Current Report on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K of LadRx Corporation (the “Company”) filed with the U.S. Securities and Exchange Commission on September 11, 2023 (the “Original Form 8-K”). The sole purpose of this Amendment is to amend and restate in its entirety, Item 5.02 of the Original Form 8-K to disclose the future grant date of certain stock options to be made by the Board of Directors (the “Board”) of the Company, which was inadvertently omitted from the Original Form 8-K. No other changes have been made to the Original Form 8-K.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 7, 2023, the Board approved the first amendment (the “Plan Amendment”) to the LadRx Corporation 2019 Stock Incentive Plan (the “Plan”), effective as of the same date. The Plan Amendment amends the Plan to (i) reflect the Company’s recent name change from CytRx Corporation to LadRx Corporation, and (ii) increase the aggregate number of shares of common stock, par value $0.001 per share (the “Common Stock”), that may be issued under the Plan, as set forth in Section 4(a) of the Plan, by an additional 75,000 shares of Common Stock.
On September 7, 2023, the Board additionally approved and set January 16, 2024 as the grant date for certain stock options to purchase shares of Common Stock to certain directors and officers of the Company, which such amounts shall be determined at a future date.
The foregoing description of the Plan Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text of the Plan Amendment, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| LADRX CORPORATION | |
| Date: October 12, 2023 | /s/ John Y. Caloz |
| John Y. Caloz | |
| Chief Financial Officer |
| This ‘8-K/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 1/16/24 | ||||
| Filed on: | 10/12/23 | |||
| 9/11/23 | 8-K | |||
| 9/7/23 | ||||
| For Period end: | 9/6/23 | 8-K | ||
| List all Filings | ||||